These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 26384312)

  • 1. Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.
    Van Sebille YZ; Stansborough R; Wardill HR; Bateman E; Gibson RJ; Keefe DM
    Curr Oncol Rep; 2015 Nov; 17(11):50. PubMed ID: 26384312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pharmacotherapy options for chemotherapy-induced alimentary mucositis.
    Wardill HR; Bowen JM; Gibson RJ
    Expert Opin Biol Ther; 2014 Mar; 14(3):347-54. PubMed ID: 24387716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis.
    Prisciandaro LD; Geier MS; Butler RN; Cummins AG; Howarth GS
    Crit Rev Food Sci Nutr; 2011 Mar; 51(3):239-47. PubMed ID: 21390944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological modulation of radiation-induced oral mucosal complications.
    Bockel S; Vallard A; Lévy A; François S; Bourdis M; Le Gallic C; Riccobono D; Annede P; Drouet M; Tao Y; Blanchard P; Deutsch É; Magné N; Chargari C
    Cancer Radiother; 2018 Sep; 22(5):429-437. PubMed ID: 29776830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change.
    Stringer AM; Gibson RJ; Bowen JM; Keefe DM
    Curr Drug Metab; 2009 Jan; 10(1):79-83. PubMed ID: 19149515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
    McDonnell AM; Lenz KL
    Ann Pharmacother; 2007 Jan; 41(1):86-94. PubMed ID: 17190850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential clinical impact of probiotic treatment for the prevention and/or anti-inflammatory therapeutic effect against radiation induced intestinal mucositis. A review.
    Maria-Aggeliki KS; Nikolaos KL; Kyrias GM; Vassilis KE
    Recent Pat Inflamm Allergy Drug Discov; 2009 Nov; 3(3):195-200. PubMed ID: 19925445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for chemotherapy-induced mucositis.
    Keefe DM; Sonis ST; Bowen JM
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):511-22. PubMed ID: 18764726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment.
    Stringer AM; Gibson RJ; Bowen JM; Logan RM; Yeoh AS; Keefe DM
    J Support Oncol; 2007 Jun; 5(6):259-67. PubMed ID: 17624050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis.
    Barasch A; Elad S; Altman A; Damato K; Epstein J
    Support Care Cancer; 2006 Jun; 14(6):528-32. PubMed ID: 16775648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity.
    Cario E
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):157-64. PubMed ID: 26986508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis for mucositis induced by ambulatory chemotherapy: systematic review.
    Manzi Nde M; Silveira RC; dos Reis PE
    J Adv Nurs; 2016 Apr; 72(4):735-46. PubMed ID: 26626711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Effectiveness of Clinically-Relevant Analgesics in a Rat Model of Chemotherapy-Induced Mucositis.
    Whittaker AL; Lymn KA; Wallace GL; Howarth GS
    PLoS One; 2016; 11(7):e0158851. PubMed ID: 27463799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.
    Beaven AW; Shea TC
    Drugs Today (Barc); 2007 Jul; 43(7):461-73. PubMed ID: 17728847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic strategies for combatting gastrointestinal toxicity.
    Sylvester CL; Anderson PH; Stringer AM
    Curr Opin Support Palliat Care; 2020 Jun; 14(2):142-152. PubMed ID: 32332213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience.
    Sougiannis AT; VanderVeen BN; Davis JM; Fan D; Murphy EA
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G712-G719. PubMed ID: 33471628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations.
    Peterson DE; Bensadoun RJ; Roila F;
    Ann Oncol; 2009 May; 20 Suppl 4():174-7. PubMed ID: 19454447
    [No Abstract]   [Full Text] [Related]  

  • 18. Gelclair: managing the symptoms of oral mucositis.
    Smith T
    Hosp Med; 2001 Oct; 62(10):623-6. PubMed ID: 11688125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective Evaluation of Palifermin Use in Nonhematopoietic Stem Cell Transplant Pediatric Patients.
    Liu D; Seyboth B; Mathew S; Gilheeney SW; Chou AJ; Drill E; Kobos R
    J Pediatr Hematol Oncol; 2017 May; 39(4):e177-e182. PubMed ID: 28234746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis.
    Blijlevens N; Sonis S
    Ann Oncol; 2007 May; 18(5):817-26. PubMed ID: 17030544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.